Simon Latimer | Head of Investor Relations |
John Higgins | Chief Executive Officer |
Matt Korenberg | Chief Financial Officer |
Matt Foehr | Chief Operating Officer |
Joe Pantginis | H.C. Wainwright |
Larry Solow | CJS Securities |
Matt Hewitt | Craig-Hallum |
Jacob Johnson | Stephens |
Scott Henry | ROTH Capital |
Good day and thank you for standing by and welcome to the Ligand Pharmaceuticals Q4 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that this call is being recorded. [Operator Instructions] I would now like to hand the conference over to your host today, Simon Latimer, Head of Investor Relations.